|
Volumn 95 Suppl B, Issue , 2001, Pages
|
Formoterol in clinical practice--safety issues.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
ETHANOLAMINE DERIVATIVE;
FORMOTEROL;
GLUCOCORTICOID;
ACUTE DISEASE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
DRUG TOLERANCE;
HUMAN;
META ANALYSIS;
NEBULIZER;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ACUTE DISEASE;
ADRENERGIC BETA-AGONISTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
DRUG TOLERANCE;
ETHANOLAMINES;
GLUCOCORTICOIDS;
HUMANS;
NEBULIZERS AND VAPORIZERS;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ADRENERGIC, BETA-2;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 0035434002
PISSN: 09546111
EISSN: None
Source Type: Journal
DOI: 10.1053/rmed.2001.1142 Document Type: Article |
Times cited : (8)
|
References (0)
|